Skip to main content
. Author manuscript; available in PMC: 2018 Apr 23.
Published in final edited form as: Cancer Res. 2010 Apr 13;70(9):3586–3593. doi: 10.1158/0008-5472.CAN-09-3197

Figure 1.

Figure 1

Kaplan-Meier estimates of cumulative incidence of CIN-III (A) and ICC (B) according to categories of serum GGT, measured at baseline. For the analysis of CIN-III, women with one or more gynecologic examinations during follow-up were included (n = 73,354); for the ICC analyses, all women were included (n = 92,843).